Comparing effect levels of regulatory studies with endpoints derived in targeted anti-androgenic studies: example prochloraz
Crossref DOI link: https://doi.org/10.1007/s00204-016-1678-y
Published Online: 2016-02-25
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Melching-Kollmuss, Stephanie
Fussell, Karma C.
Schneider, Steffen
Buesen, Roland
Groeters, Sibylle
Strauss, Volker
van Ravenzwaay, Bennard
Text and Data Mining valid from 2016-02-25